| 
 (S)-Methylarginine 
 | 
|
| Names | |
|---|---|
| Other names
 2-Amino-5-[(N’-methylcarbamimidoyl)amino]pentanoic acid; N-Monomethylarginine; omega-N-Methylarginine 
 | 
|
| Identifiers | |
| 
17035-90-4 (S)  | 
|
| 3D model (Jmol) | 
Interactive image Interactive image  | 
| 2262067 (R) | |
| ChEBI | 
CHEBI:28229  | 
| ChEMBL | 
ChEMBL312870  ChEMBL109350 ChEMBL256147  | 
| ChemSpider | 
4213  2015298 (R) 117259 (S)  | 
| KEGG | 
C03884  | 
| MeSH | omega-N-Methylarginine | 
| PubChem | 
4366 2733510 (R) 132862 (S)  | 
  | 
|
  | 
|
| Properties | |
| C7H16N4O2 | |
| Molar mass | 188.23 g·mol−1 | 
| log P | −0.63 | 
| Acidity (pKa) | 2.512 | 
| Basicity (pKb) | 11.488 | 
| Related compounds | |
| 
 Related alkanoic acids 
 | 
|
| 
 Related compounds 
 | 
|
| 
 Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). 
 | 
|
| 
 | 
|
| Infobox references | |
N-Methylarginine is an inhibitor of nitric oxide synthase. Chemically, it is a methyl derivative of the amino acid arginine. It is used as a biochemical tool in the study of physiological role of nitric oxide.
The inhibiting effect of N-methylarginine on vasodilation is lower in hypertensive patients than in normal subjects, indicating endothelial dysfunction. The inhibiting effect of N-methylarginine on vasodilation declines progressively with age, but has been restored with vitamin C (except in the oldest subjects).